IDSA GUIDELINES Bundle (free trial)

Antibiotic Stewardship 2016

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/662041

Contents of this Issue

Navigation

Page 2 of 7

Interventions Table 1. Comparison of Preauthorization and Prospective Audit and Feedback Strategies for Antibiotic Stewardship Preauthorization Prospective Audit and Feedback Advantages • Reduces initiation of unnecessary/ inappropriate antibiotics • Optimizes empiric choices and influences downstream use • Prompts review of clinical data/ prior cultures at the time of initiation of therapy • Decreases antibiotic costs, including those due to high-cost agents • Provides mechanism for rapid response to antibiotic shortages • Direct control over antibiotic use • Can increase visibility of ASP and build collegial relationships • More clinical data available for recommendations, enhancing uptake by prescribers • Greater flexibility in timing of recommendations • Can be done on less than daily basis if resources are limited • Provides educational benefit to clinicians • Prescriber autonomy maintained • Can address de-escalation of antibiotics and duration of therapy Disadvantages • Impacts use of restricted agents only • Addresses empiric use to a much greater degree than downstream use • Loss of prescriber autonomy • May delay therapy • Effectiveness depends on skill of approver • Real-time resource intensive • Potential for manipulation of system (e.g., presenting request in a biased manner to gain approval) • May simply shift to other antibiotic agents and select for different antibiotic-resistance patterns • Compliance voluntary • Typically labor-intensive • Success depends on delivery method of feedback to prescribers • Prescribers may be reluctant to change therapy if patient is doing well • Identification of interventions may require information technolog y support and/or purchase of computerized surveillance systems • May take longer to achieve reductions in targeted antibiotic use

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Antibiotic Stewardship 2016